1-99892547-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000642.3(AGL):​c.3199C>T​(p.Pro1067Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.14 in 1,612,830 control chromosomes in the GnomAD database, including 16,526 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1067A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.14 ( 1508 hom., cov: 32)
Exomes 𝑓: 0.14 ( 15018 hom. )

Consequence

AGL
NM_000642.3 missense

Scores

1
6
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 7.28
Variant links:
Genes affected
AGL (HGNC:321): (amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase) This gene encodes the glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in this gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0034675002).
BP6
Variant 1-99892547-C-T is Benign according to our data. Variant chr1-99892547-C-T is described in ClinVar as [Benign]. Clinvar id is 256734.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.144 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGLNM_000642.3 linkc.3199C>T p.Pro1067Ser missense_variant Exon 24 of 34 ENST00000361915.8 NP_000633.2 P35573-1A0A0S2A4E4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGLENST00000361915.8 linkc.3199C>T p.Pro1067Ser missense_variant Exon 24 of 34 1 NM_000642.3 ENSP00000355106.3 P35573-1

Frequencies

GnomAD3 genomes
AF:
0.136
AC:
20704
AN:
151914
Hom.:
1507
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.120
Gnomad AMI
AF:
0.221
Gnomad AMR
AF:
0.127
Gnomad ASJ
AF:
0.182
Gnomad EAS
AF:
0.0262
Gnomad SAS
AF:
0.149
Gnomad FIN
AF:
0.169
Gnomad MID
AF:
0.193
Gnomad NFE
AF:
0.146
Gnomad OTH
AF:
0.148
GnomAD3 exomes
AF:
0.134
AC:
33763
AN:
251154
Hom.:
2513
AF XY:
0.138
AC XY:
18769
AN XY:
135738
show subpopulations
Gnomad AFR exome
AF:
0.117
Gnomad AMR exome
AF:
0.0998
Gnomad ASJ exome
AF:
0.191
Gnomad EAS exome
AF:
0.0294
Gnomad SAS exome
AF:
0.145
Gnomad FIN exome
AF:
0.167
Gnomad NFE exome
AF:
0.150
Gnomad OTH exome
AF:
0.148
GnomAD4 exome
AF:
0.141
AC:
205269
AN:
1460798
Hom.:
15018
Cov.:
33
AF XY:
0.141
AC XY:
102608
AN XY:
726728
show subpopulations
Gnomad4 AFR exome
AF:
0.119
Gnomad4 AMR exome
AF:
0.105
Gnomad4 ASJ exome
AF:
0.186
Gnomad4 EAS exome
AF:
0.0303
Gnomad4 SAS exome
AF:
0.144
Gnomad4 FIN exome
AF:
0.169
Gnomad4 NFE exome
AF:
0.143
Gnomad4 OTH exome
AF:
0.140
GnomAD4 genome
AF:
0.136
AC:
20697
AN:
152032
Hom.:
1508
Cov.:
32
AF XY:
0.137
AC XY:
10206
AN XY:
74308
show subpopulations
Gnomad4 AFR
AF:
0.120
Gnomad4 AMR
AF:
0.126
Gnomad4 ASJ
AF:
0.182
Gnomad4 EAS
AF:
0.0263
Gnomad4 SAS
AF:
0.150
Gnomad4 FIN
AF:
0.169
Gnomad4 NFE
AF:
0.146
Gnomad4 OTH
AF:
0.145
Alfa
AF:
0.141
Hom.:
3934
Bravo
AF:
0.129
TwinsUK
AF:
0.137
AC:
508
ALSPAC
AF:
0.142
AC:
548
ESP6500AA
AF:
0.126
AC:
557
ESP6500EA
AF:
0.146
AC:
1257
ExAC
AF:
0.136
AC:
16506
Asia WGS
AF:
0.0940
AC:
327
AN:
3476
EpiCase
AF:
0.157
EpiControl
AF:
0.157

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glycogen storage disease type III Benign:4
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:2
Dec 02, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
Dec 15, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
23
DANN
Benign
0.97
DEOGEN2
Benign
0.22
T;T;T;T;.
Eigen
Benign
-0.021
Eigen_PC
Benign
0.034
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.93
D;.;.;.;D
MetaRNN
Benign
0.0035
T;T;T;T;T
MetaSVM
Benign
-0.59
T
MutationAssessor
Benign
1.6
L;L;L;L;.
PrimateAI
Uncertain
0.55
T
PROVEAN
Uncertain
-2.7
D;D;D;D;D
REVEL
Uncertain
0.29
Sift
Uncertain
0.027
D;D;D;D;D
Sift4G
Uncertain
0.048
D;D;D;D;T
Polyphen
0.15
B;B;B;B;B
Vest4
0.42
MPC
0.048
ClinPred
0.078
T
GERP RS
5.2
Varity_R
0.17
gMVP
0.67

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3753494; hg19: chr1-100358103; API